Read Roche's Latest Drug Marks a Milestone in KRAS-Driven Lung Cancer Treatment LifeMedicine Roche's Latest Drug Marks a Milestone in KRAS-Driven Lung Cancer Treatment Roche's new drug has been approved, potentially setting a new standard for treating KRAS-driven lung cancer, amidst a thriving biotech sector. Editorial Staff 13 days ago
